Ondansetron and chemotherapy induced emesis 3rd International Congress on Neo-adjuvant Chemotherapy
-
- Englisch ausgewählt
Fr. 137.00
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
01.02.1992
Herausgeber
M. Marty + weitereVerlag
Springer BerlinSeitenzahl
78
Maße (L/B/H)
24.4/17/0.6 cm
Gewicht
200 g
Auflage
Softcover reprint of the original 1st ed. 1991
Sprache
Englisch
ISBN
978-3-540-54599-6
During the 3rd International Congress on Neoadjuvant
Chemotherapy (Paris 1991) a complete symposium was devoted
to chemically induced nausea and vomiting and to the value
of Ondansetron. This book comprises original articles
dealing with the different topics discussed during this
session. It provides fuller information on current practice
in anti-emetic treatment during anti-cancerous chemotherapy
and sets out the position of a new and important drug,
ondansetron, in this pathology. Different international
clinical studies made with ondansetron in various types of
patients are analysed: specific studies in hematology or in
pulmonary disease, evaluation against benzamide-corticoid as
a combined reference standard, or further the additive
effect of a corticoid combined with ondansetron. One article
is devoted to the use of the drug in children. Finally,
recent programmes dealing with both the intravenous and the
oral use of ondansetron are assessed. The last article deals
with the economic evaluation of the use of ondansetron. Thus
the reader will findhere a recent and uo-to-date review of
the results and possible uses of ondansetron, now the
premier member of the class of 5 HT 3 antagonists, in
chemically induced nausea and vomiting.
Chemotherapy (Paris 1991) a complete symposium was devoted
to chemically induced nausea and vomiting and to the value
of Ondansetron. This book comprises original articles
dealing with the different topics discussed during this
session. It provides fuller information on current practice
in anti-emetic treatment during anti-cancerous chemotherapy
and sets out the position of a new and important drug,
ondansetron, in this pathology. Different international
clinical studies made with ondansetron in various types of
patients are analysed: specific studies in hematology or in
pulmonary disease, evaluation against benzamide-corticoid as
a combined reference standard, or further the additive
effect of a corticoid combined with ondansetron. One article
is devoted to the use of the drug in children. Finally,
recent programmes dealing with both the intravenous and the
oral use of ondansetron are assessed. The last article deals
with the economic evaluation of the use of ondansetron. Thus
the reader will findhere a recent and uo-to-date review of
the results and possible uses of ondansetron, now the
premier member of the class of 5 HT 3 antagonists, in
chemically induced nausea and vomiting.
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.